TriSalus CEO Szela surrenders 2,693 shares
TriSalus Life Sciences CEO Szela Mary T surrendered 2,693 shares at $4.38 per share, for $11,795, reported on Form 4.
TriSalus Life Sciences CEO Szela Mary T surrendered 2,693 shares at $4.38 per share, for $11,795, reported on Form 4.